Replies to post #443656 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

MI Dendream,

It’s in the bag (and in the third party exceptions to otherwise expected disclosures). Best wishes

[exwannabe]

ATL et al, Thank you for putting these pieces together so clearly and concisely.

From what you day this also puts to rest the update the clincialtrials.gov or else crowd too. They are acknowledging the need for secrecy at times during the regulatory process and leave that to the discretion of the company through a quiet period.

The paper, sourced by mueee, is an excellent read. One should read the entire paper.

Look at this graphic from the paper as a quick start.

The timeline is post trial completion (not datalock).

Within 12 months of completion is summary data and "lay results". I.E, the registry update and a PR.

Sometime between that and 18 months is a publication. This is still not the full data being described.

By 18 months they should make the "full data" available.

Trial completion (and the paper discusses what that means) comes when they have the last data from the clinics. It was at least 20 months ago in this trial.

P.S., the paper also says the SAP is submitted at trial design and finalized prior to completion. Odd that supposedly NWBO never submitted a SAP until way late.